|本期目录/Table of Contents|

[1]赵一楠,周迎生.重视糖尿病患者的心血管保护——新指南新观点新建议[J].慢性病学杂志,2015,(02):129-131.
点击复制

重视糖尿病患者的心血管保护——新指南新观点新建议(PDF)

《慢性病学杂志》[ISSN:1674-8166/CN:11-5900/R]

卷:
期数:
2015年02期
页码:
129-131
栏目:
述评
出版日期:
2015-04-30

文章信息/Info

Title:
-
作者:
赵一楠;  周迎生
首都医科大学附属北京安贞医院内分泌代谢科，北京市心肺血管疾病研究所，北京100029
Author(s):
-
关键词:
糖尿病; 心血管疾病; 指南; 并发症
Keywords:
-
分类号:
R587.1
DOI:
-
摘要:
-
Abstract:
-

参考文献/References:

[1] Grundy SM, Benjamin IJ, Burke GL, et al. Diabetes and car? diovascular disease: a statement for healthcare professionals from the American Heart Association ［J］．Circulation, 1999, 100(10):1134-1146.
[2］ Morrish NJ, Wang SL, Stevens LK, et al. Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes ［J］． Diabetologia, 2001,44(Suppl 2): S14-21.
[3］ World Health Organization. The top 10 causes of death: report of WHO Scientific Group ［R］． Geneva: WHO, 2014.
[4］ 中华医学会糖尿病学分会.中国2 型糖尿病防治指南(2010 年 版) ［J］．中国糖尿病杂志,2012,20(1):13-14.
[5］ Authors/Task Force Members, Ryden L, Grant PJ, et al. ESC Guidelines on diabetes, pre- diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre- diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD) ［J］． Eur Heart J, 2013,34(39):3035- 3087.
[6］ Belch J, MacCuish A, Campbell I, et al. The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and anti? oxidants in patients with diabetes and asymptomatic peripheral arterial disease ［J］． BMJ, 2008,337:a1840.
[7］ Ogawa H, Nakayama M, Morimoto T, et al. Low-dose aspi? rin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial ［J］． JA? MA, 2008,300(18):2134-2141.
[8］ American Diabetes Association. Standards of medical care in di abetes-2014 ［J］．Diabetes Care, 2014,37(Suppl 1):S14-80.
[9］ Stratton IM, Adler AI, Neil HA, et al. Association of glycae? mia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study ［J］． BMJ, 2000,321:405-412.
[10］ Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, et al. Effects of intensive glucose lowering in type 2 diabetes ［J］． New Engl J Med, 2008,358(24):2545-2559.
[11］ Duckworth W, Abraira C, Moritz T, et al. Glucose control and vascular complications in veterans with type 2 diabetes ［J］． New Engl J Med, 2009,360(2):129-139.
[12］ ADVANCE Collaborative Group, Patel A, MacMahon S, et al. Intensive blood glucose control and vascular outcomes in pa? tients with type 2 diabetes ［J］． New Engl J Med, 2008,358 (24):2560-2572.
[13］ 中华医学会糖尿病学分会.中国2 型糖尿病防治指南(2013 年版) ［J］．中国糖尿病杂志,2014,22(8):105-145.
[14］ Collaborative overview of randomised trials of antiplatelet ther? apy- I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of pa? tients. Antiplatelet Trialists' Collaboration ［J］． BMJ, 1994, 308(6921):81-106.

备注/Memo

备注/Memo:
基金项目： 国家自然科学基金资助项目（81041024）； 教育部留学回国基金资助项目（2012-940）； 北京市科委科研基金资助项目 （Z131100004013044）；北京市学科带头人基金 资助项目（2013-2-006） 作者简介： 赵一楠， 在读博士生， 研究方向为2 型糖尿 病、肥胖发病机制及心血管并发症防治 通信作者： 周迎生，教授，主任医师，博士生导师，Email: zhouys01@sina.cn
更新日期/Last Update: 2015-04-15